Back to Search
Start Over
Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors?
- Source :
- Circ Cardiovasc Qual Outcomes
- Publication Year :
- 2020
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2020.
- Subjects :
- medicine.medical_specialty
Serine Proteinase Inhibitors
Databases, Factual
Cost-Benefit Analysis
Treatment outcome
MEDLINE
Drug Costs
Article
Risk Factors
medicine
Humans
Practice Patterns, Physicians'
Intensive care medicine
PCSK9 Inhibitors
Drug Approval
Dyslipidemias
Randomized Controlled Trials as Topic
Extramural
Practice patterns
business.industry
Anticholesteremic Agents
Lipids
United States
Treatment Outcome
Cardiovascular Diseases
Cardiology and Cardiovascular Medicine
business
Cardiovascular outcomes
Biomarkers
Subjects
Details
- ISSN :
- 19417705 and 19417713
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Circulation: Cardiovascular Quality and Outcomes
- Accession number :
- edsair.doi.dedup.....5f6e42eb7768a168e4e684d93be5b403